Impulsivity Domains and Subjective Response

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

September 1, 2027

Study Completion Date

September 1, 2027

Conditions
Alcohol Use Disorder
Interventions
DRUG

Placebo

Participants receive placebo (saline) intravenously. They will also have the opportunity to self-administer saline during the 60-minute free-access IV self-administration period in session 3.

DRUG

Alcohol

Participants receive alcohol intravenously, clamped at BrACs of 20mg%, 40mg%, and 60mg%. They will also have the opportunity to self-administer alcohol (up to 120mg% BrAC) during the 60-minute free-access IV self-administration period in session 3.

Trial Locations (2)

43221

RECRUITING

Ohio State University, Columbus

02115

RECRUITING

Northeastern University, Boston

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Jessica Weafer

OTHER